QIULE SEEDS
831087
OFDY
839371
KANGNONG SEED
837403
4
Hainan Shennong Seed Industry Technology
300189
5
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 4.410
- -0.110-2.43%
Trading Apr 7 12:42 ET
239.63MMarket Cap-1.23P/E (TTM)
4.810High4.120Low485.63KVolume4.280Open4.520Pre Close2.16MTurnover0.92%Turnover RatioLossP/E (Static)54.34MShares15.10052wk High0.50P/B233.55MFloat Cap1.82052wk Low--Dividend TTM52.96MShs Float137.610Historical High--Div YieldTTM15.27%Amplitude1.420Historical Low4.451Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Emergent BioSolutions Stock Forum
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...
Emergent BioSolutions Announces Stock Repurchase Program
Monday, 31st March at 8:00 am
GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company's common stock on or before March 27, 2026.
"As Emergent continues the turnaround phase of our multi-year transformation plan, we expect our investment priorities to remain f...
Emergent BioSolutions Inc - Authorizes $50 Million Stock Repurchase Program
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Thursday, 20th March at 8:06 am
LONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected opioid overdose, as manifested by respiratory and/or central ner...
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Wednesday, 19th March at 4:30 pm
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International. Emergent received approximately $36.5 million at closing, which is subject to customary post-closing...
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products
to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
Thursday, 13th March at 8:29 am
NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving medicine
Leading mental health and addiction treatment services provider, Pathway Healthcare, breaks down stigma and access ...
2 MINUTES AGO, 8:29 AM EDT
VIA GLOBENEWSWIRE
NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving medicine
Leading mental health and addiction treatment services p...
No comment yet